Case Report: BKV-specific T cells: a fast, safe and potentially effective treatment option for refractory BKV infections in pediatric patients after allogeneic stem cell transplantation. [PDF]
Front PediatrOberwegner S +6 more
europepmc +1 more source
Evaluating the advancements and efficacies in pharmacological Mpox treatments: a comprehensive review. [PDF]
Front PharmacolHudu SA +4 more
europepmc +1 more source
Mpox: disease manifestations and therapeutic development. [PDF]
J VirolWang Y +5 more
europepmc +1 more source
From outbreak to opportunity: Sierra Leone's mpox crisis as a wakeup call for pandemic equity. [PDF]
Int J Equity HealthBai-Sesay AU, Jones RD, Sesay DKD.
europepmc +1 more source
Tecovirimat is active against various MPXV strains, while cidofovir, brincidofovir, trifluridine, and gemcitabine have no detectable MPXV-specific antiviral activity. [PDF]
Virus ResHigashi-Kuwata N +4 more
europepmc +1 more source
Therapeutic Innovations for Monkeypox Inhibition. [PDF]
Int J Mol SciDe N +5 more
europepmc +1 more source
Lactoferrin blocks orthopoxvirus entry via heparan sulphate and regulates host antiviral pathways. [PDF]
Emerg Microbes InfectTian L +15 more
europepmc +1 more source
In-silico discovery of type-2 diabetes-causing host key genes that are associated with the complexity of monkeypox and repurposing common drugs. [PDF]
Brief BioinformAjadee A +5 more
europepmc +1 more source
Mpox vaccine in the Philippines: the waiting continues, but until when? [PDF]
Ther Adv Vaccines ImmunotherCordero DA.
europepmc +1 more source
Vaccines and Antiviral Therapies for Mpox Virus in Pregnant and Breastfeeding Women: Efficacy and Maternal-Child Outcomes. [PDF]
VirusesImran M +5 more
europepmc +1 more source